Top and Current
Source : (remove) : PharmExec
RSS • JSON • XML • CSV
Top and Current
Source : (remove) : PharmExec
RSS • JSON • XML • CSV

Johnson & Johnson to Invest Over $55 Billion in US Manufacturing Facilities

The investment, which is a 25% increase from previous years, will support three new advanced manufacturing facilities, expansions at existing sites, and R&D efforts.
Johnson & Johnson has announced plans to invest over $55 billion in its U.S. manufacturing facilities over the next five years, aiming to enhance its supply chain resilience and support the production of critical medicines and medical devices. This investment will focus on expanding and upgrading facilities across several states including California, Indiana, North Carolina, Ohio, Pennsylvania, and Washington. The initiative is part of a broader strategy to not only increase production capacity but also to foster innovation, create jobs, and ensure that the company can meet future healthcare demands. This move is also seen as a response to recent global supply chain disruptions, emphasizing the importance of domestic manufacturing capabilities. The investment will also contribute to local economies by creating thousands of jobs and supporting community development.

Read the Full PharmExec Article at:
[ https://www.pharmexec.com/view/johnson-johnson-invest-over-55-billion-us-manufacturing-facilities ]